Alabama Senate Bill SB351

Alabama 2026 Regular Session

• Introduced: 3/10/26
• Refer: 3/10/26
• Report Pass: 3/17/26

Caption

Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

Impact

The proposed legislation amends several sections of Alabama's Code, including Sections 16-1-39, 16-1-48, and 22-1-16, focusing on enhancing the state's anaphylaxis preparedness programs. Schools must develop operational protocols in collaboration with healthcare professionals. The law mandates training programs for school personnel, which will now also cover various authorized epinephrine delivery systems, ensuring staff are equipped to handle emergencies effectively. This shift enhances the scope of care that schools can provide in life-threatening situations.

Summary

SB351 aims to enhance public health regulations by expanding the approved forms of epinephrine that can be carried and self-administered by students in Alabama public schools. Currently, the law restricts this to single-dose autoinjectable epinephrine, but the bill proposes allowing any FDA-approved form of single-dose premeasured epinephrine. This change is intended to equip schools and authorized entities better to respond to life-threatening allergic reactions, ultimately promoting the safety and health of students vulnerable to anaphylaxis.

Conclusion

Overall, SB351 signifies a proactive approach to enhancing health safety in schools in Alabama by improving access to life-saving interventions for allergic reactions. It is a step towards ensuring that schools are better prepared to safeguard the health of their students, reflecting a growing awareness of the need for comprehensive health policies in educational environments.

Contention

While there is overarching support for improved health responses in schools, some contention arises regarding liability and the implementation of training programs. Concerns have been raised about the potential legal implications if an epinephrine delivery system is misadministered or if training is insufficient. To mitigate these concerns, SB351 includes provisions for legal immunity for individuals involved in administering epinephrine in good faith. Critics, however, may argue this could reduce accountability in the training and administration processes.